Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer
Not Applicable
- Conditions
- Advanced or recurrent gastric and colorectal cancer
- Registration Number
- JPRN-UMIN000004572
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy Uncontrolled infection Patients with serious concomitant disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We confirm the safety of the peptide vaccine against gastric and colorectal cancer patient.
- Secondary Outcome Measures
Name Time Method